7 Stocks to Buy That Love Rising Interest Rates

In This Article:

A double-edged sword if there ever was one, the September jobs report effectively put the Federal Reserve in a bind, catalyzing the case for stocks for rising interest rates. Sure, on the one hand, most governments aim for a robust labor market. Happy, employed workers obviously tend to be satisfied, thus reducing pressure on policymakers.

However, a darker side exists to a surprisingly strong print. For the Fed, that dark side threatens to undermine its efforts to contain inflation. Mathematically, we’re talking about more dollars chasing after fewer goods, which is the exact opposite of what the central bank wants at the moment. Therefore, spiked borrowing costs may be in order, thus the relevance of stocks for rising interest rates.

Of course, the Fed can’t go all Rambo on inflation and spike rates to the moon. Otherwise, the economy will almost surely fall into recession. But not doing enough can also cause long-lasting pain. With such a delicate balancing act at play, investors may want to consider these stocks for rising interest rates.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Allstate (ALL)

Allstate Insurance office
Allstate Insurance office

Source: Jonathan Weiss / Shutterstock.com

An insurance giant, Allstate (NYSE:ALL) benefits from a captive audience. Sure, I suppose it’s possible to go through life without financially securing your most important assets. However, with so many disasters liable to destroy your dreams in an instant, it’s extremely foolish to do so. Basically, Allstate “preys” on that very reasonable fear, making it one of the top stocks for rising interest rates.

Notably, Allstate doesn’t exactly offer sterling financials. For example, its balance sheet could use some shoring up, particularly with its high debt load relative to cash. Also, the company’s trailing-year net margin sits 4.8% below breakeven. However, on the positive side, Allstate prints a three-year revenue growth rate of 14.2%, above 81.84% of sector rivals.

Better yet, ALL trades at only 0.57x trailing revenue. That’s noticeably below the sector median value of 0.95x. Finally, analysts rate ALL a consensus moderate buy with a $129.33 price target, implying over 7% growth.

MetLife (MET)

Man in suit with hands over paper cutouts of family, car and home. Represents insurance.
Man in suit with hands over paper cutouts of family, car and home. Represents insurance.

Source: thodonal88 / Shutterstock.com

One of the largest global providers of insurance, annuities and employee benefit programs, MetLife (NYSE:MET) might not be a particularly exciting enterprise. Nevertheless, as a provider of key relevant services, MET ranks among the best stocks for rising interest rates. Admittedly, its performance in the charts – down 14% on a year-to-date basis – doesn’t provide confidence right now. However, that could change over time.